Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D01UNC
|
||||
Former ID |
DNC013624
|
||||
Drug Name |
2-(4-aminophenylsulfonamido)acetic acid
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [1] | ||
Structure |
![]() |
Download2D MOL |
|||
Formula |
C8H10N2O4S
|
||||
Canonical SMILES |
C1=CC(=CC=C1N)S(=O)(=O)NCC(=O)O
|
||||
InChI |
1S/C8H10N2O4S/c9-6-1-3-7(4-2-6)15(13,14)10-5-8(11)12/h1-4,10H,5,9H2,(H,11,12)
|
||||
InChIKey |
BPJUMYMTQYMSFZ-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Aldose reductase | Target Info | Inhibitor | [1] | |
BioCyc Pathway | Methylglyoxal degradation III | ||||
Acetone degradation I (to methylglyoxal) | |||||
KEGG Pathway | Pentose and glucuronate interconversions | ||||
Fructose and mannose metabolism | |||||
Galactose metabolism | |||||
Glycerolipid metabolism | |||||
Metabolic pathways | |||||
NetPath Pathway | IL1 Signaling Pathway | ||||
TGF_beta_Receptor Signaling Pathway | |||||
PathWhiz Pathway | Fructose and Mannose Degradation | ||||
Pyruvate Metabolism | |||||
Pterine Biosynthesis | |||||
Glycerolipid Metabolism | |||||
Galactose Metabolism | |||||
WikiPathways | Metapathway biotransformation | ||||
Polyol Pathway | |||||
Metabolism of steroid hormones and vitamin D | |||||
References | |||||
REF 1 | Bioorg Med Chem. 2008 Apr 1;16(7):3926-32. Epub 2008 Jan 30.Design and synthesis of N-(3,5-difluoro-4-hydroxyphenyl)benzenesulfonamides as aldose reductase inhibitors. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.